Article History
Received: 28 August 2023
Accepted: 25 October 2023
First Online: 21 November 2023
Declarations
:
: Elisa Agostinetto, Evandro de Azambuja and Luca Arecco declare no conflicts of interest that might have influence the content of this article. Elisa Agostinetto: Consultancy fee or honoraria: Eli Lilly, Sandoz, AstraZeneca. Research grant to my Institution from Gilead. Support for attending medical conferences from Novartis, Roche, Eli Lilly, Genetic, Istituto Gentili, Daiichi Sankyo, AstraZeneca (all outside the submitted work). Luca Arecco: Changed his affiliation during the completion of this manuscript (previous affiliation: IRCCS Ospedale Policlinico San Martino, Genova, Italy; current affiliation: Institut Jules Bordet, Brussels, Belgium, and IRCCS Ospedale Policlinico San Martino, Genova, Italy). Evandro de Azambuja: Honoraria and/or advisory board from Roche/GNE, Novartis, SeaGen, Zodiac, Libbs, Pierre Fabre, Lilly, AstraZeneca, MSD, Gilead Sciences. Travel grants from Roche/GNE and AstraZeneca. Research grant to my institution from Roche/GNE, AstraZeneca, and GSK/Novartis, Gilead Sciences. Non-financial: ESMO director of Membership 2023–2024, BSMO President 2023–2026.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.